[1] 肖恩华,胡国东,李锦清,等.经导管动脉化疗栓塞治疗肝细胞癌的疗效观察[J].中华肿瘤杂志,2005,27(8):478-482.
[2] Zhou WP,Lai EC,Li AJ,et al.A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma[J].Ann Surg ,2009,249(2):195-202.
[3] Cristofori C, Cardin R, Pivetta G, et al.Transcatheter arterial chemoembolization(TACE) in hepatocellular carcinoma(HCC):the role of angiogenesis and invasiveness[J]. Am J Gastroenterol,2008,103(4):914-921.
[4] 吴孟超.肝脏外科学[M].上海:上海科学技术文献出版社,2000:589-590.
[5] Poon RT,Ronnie TP.From molecular biology to targeted for hepatocellular carcinoma: the future is now[J]. Oncology,2007,72(1):30-44.
[6] Park JW,Lee JA,Park JE,et al.Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients[J].Hepatology,2007,46(2):446-455.
[7] Chen QM,Millar HJ,McCabe FL, et al. Alphav integrin-targeted immunoconjugates regress established human tumors in xenograft models[J].Clin Cancer Res,2007,13(12):3689-3695.
[8] Mimoun N,Zakia H,Geraldine G,et al. Expression,Regulation,and Function of αv integrins in hepatocellular carcinoma:An in vivo and in vitro study[J]. Hepatology,2002,36(2):418-426.
[9] Kim HJ,Chung H,Yoo YG, et al.Inhibitor of DNA binding 1 actvates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1 alpha[J].Mol Cancer Res,2007,5(4):321-329.
[10]Tai MH, Huang CC, Wang CC, et al. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma(HCC) and adverse outcome of HCC patients[J]. J Surg Oncol,2008,98(5):349-357.
[1]曹清心,汪 晨,刘 宇,等.蜂毒素对人肝癌细胞中HMGB1及VEGF-C表达的影响[J].医学研究与战创伤救治(原医学研究生学报),2012,14(02):101.
CAO Qing-xin,WANG Chen,LIU Yu,et al.Effect of melittin on high mobility group box 1 and vascular endothelial growth factors C expressions in hepatocarcinoma cells[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(03):101.
[2]沈国栋 综述,江淑芳 校审.肝细胞癌症围术期的输血治疗研究进展[J].医学研究与战创伤救治(原医学研究生学报),2014,16(02):184.[doi:10.3969/j.issn.1672-271X.2014.02.023]
[3]周昊,封冰综述,王锐审校.MicroRNA调控肝细胞癌EMT 和细胞外基质重塑的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2020,22(3):277.[doi:10.3969/j.issn.1672-271X.2020.03.012]
ZHOU Hao,FENG Bing reviewing,WANG Rui checking.The research progress of MicroRNA to regulate EMT and extracellular matrix remodeling in hepatocellular carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(03):277.[doi:10.3969/j.issn.1672-271X.2020.03.012]
[4]郭晶晶,徐瀚峰,朱传东,等.N-myc下游调控基因1在肝细胞癌中的表达及其与预后的相关性[J].医学研究与战创伤救治(原医学研究生学报),2021,23(01):21.[doi:10.3969/j.issn.1672-271X.2021.01.001]
GUO Jing-jing,XU Han-feng,ZHU Chuan-dong,et al.The expression and prognosis of NDRG1 in hepatocellular carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(03):21.[doi:10.3969/j.issn.1672-271X.2021.01.001]